Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Boundless Bio Inc (BOLD)
Fair Value11.9% Upside Fair Analyst36.5% Upside Market Cap64.917 M P/E-1.0x Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks
BridgeBio Oncology Therapeutics Inc (BBOT)
Fair Value-7.7% Downside Fair Analyst165.2% Upside Market Cap747.4 M P/E-4.8x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Bright Minds Biosciences Inc (DRUG)
Fair Value10.6% Upside Fair Analyst114.1% Upside Market Cap781.4 M P/E-39.8x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Camp4 Therapeutics Inc (CAMP)
Fair Value-16.8% Downside Fair Analyst102.0% Upside Market Cap220.2 M P/E-2.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Canton Strategic Holdings Inc (CNTN)
Fair Value53.7% Upside Bargain Market Cap144.2 M P/E-1.8x Yield0.0% HealthFair
  NASDAQ
Cardio Diagnostics Holdings Inc (CDIO)
Fair Value39.9% Upside Undervalued Market Cap5.297 M P/E-0.8x Yield0.0% HealthFair
  NASDAQ
Caris Life Sciences Inc (CAI)
Fair Value-13.3% Downside Fair Analyst15.6% Upside Market Cap6.426 B P/E62.0x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks
CG Oncology Inc (CGON)
Fair Value4.4% Upside Fair Analyst20.6% Upside Market Cap6.657 B P/E-29.8x Yield0.0% HealthFair
  NASDAQ
Citius Oncology Inc (CTOR)
Fair Value15.1% Upside Fair Analyst433.3% Upside Market Cap70.015 M P/E-1.6x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Compass Therapeutics, Inc. (CMPX)
Fair Value-18.1% Downside Overvalued Analyst305.3% Upside Market Cap387.2 M P/E-5.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Coya Therapeutics Inc (COYA)
Fair Value0.9% Upside Fair Analyst226.5% Upside Market Cap112.8 M P/E-5.2x Yield0.0% HealthFair
  NASDAQ
Creative Medical Technology Holdings Inc (CELZ)
Fair Value-4.1% Downside Fair Market Cap5.249 M P/E-0.8x Yield0.0% HealthWeak
  NASDAQ
CytoMed Therapeutics Ltd (GDTC)
Fair Value4.8% Upside Fair Market Cap9.718 M P/E-3.1x Yield0.0% HealthFair
  NASDAQ
Eikon Therapeutics Inc (EIKN)
Fair Value12.1% Upside Fair Analyst159.1% Upside Market Cap502.9 M P/E-1.5x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
EnGene Therapeutics Inc (ENGN)
Fair Value35.3% Upside Undervalued Analyst86.7% Upside Market Cap120.6 M P/E-0.9x Yield0.0% HealthWeak
  NASDAQ
Entrada Therapeutics Inc (TRDA)
Fair Value13.6% Upside Fair Analyst162.6% Upside Market Cap247.7 M P/E-1.5x Yield0.0% HealthWeak
  NASDAQ
Estrella Immunopharma Inc (ESLA)
Fair Value-3.9% Downside Fair Market Cap31.094 M P/E-2.3x Yield0.0% HealthWeak
  NASDAQ
Eupraxia Pharmaceuticals Inc (EPRX)
Fair Value-22.7% Downside Overvalued Analyst141.0% Upside Market Cap443.3 M P/E-9.4x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
EXoZymes Inc (EXOZ)
Fair Value-56.6% Downside Expensive Market Cap46.509 M P/E-4.8x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Fibrobiologics Inc (FBLG)
Fair Value24.3% Upside Undervalued Market Cap6.5 M P/E-0.4x Yield0.0% HealthWeak
  NASDAQ
Genelux Corp (GNLX)
Fair Value12.6% Upside Fair Analyst561.6% Upside Market Cap118.1 M P/E-3.6x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Genenta Science SpA ADR (GNTA)
Fair Value44.6% Upside Undervalued Analyst417.3% Upside Market Cap30.668 M P/E-4.1x Yield0.0% HealthFair
  NASDAQ
Generate Biomedicines Inc (GENB)
Fair Value-22.9% Downside Overvalued Analyst75.3% Upside Market Cap1.842 B P/E-6.8x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Grail Inc (GRAL)
Fair Value-31.6% Downside Overvalued Analyst-6.9% Downside Market Cap3.103 B P/E-8.4x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum
Greenland Mines Ltd (GRML)
Fair Value25.7% Upside Undervalued Market Cap23.52 M P/E-1.0x Yield0.0% HealthWeak
  NASDAQ
Hyperliquid Strategies Inc (PURR)
Fair Value-5.5% Downside Fair Analyst96.8% Upside Market Cap916.8 M Yield0.0% HealthGreat
  NASDAQ Featured in Small-Cap Stocks
Immix Biopharma Inc (IMMX)
Fair Value-29.3% Downside Overvalued Analyst93.9% Upside Market Cap695.4 M P/E-17.8x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Inhibrx Biosciences Inc (INBX)
Fair Value-43.8% Downside Overvalued Analyst204.1% Upside Market Cap1.301 B P/E-10.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Intensity Therapeutics Inc (INTS)
Fair Value35.2% Upside Undervalued Analyst476.7% Upside Market Cap11.244 M P/E-1.0x Yield0.0% HealthFair
  NASDAQ
Jyong Biotech Ltd (MENS)
Fair Value-11.3% Downside Fair Market Cap150.7 M P/E-32.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Kyverna Therapeutics Inc (KYTX)
Fair Value-5.2% Downside Fair Analyst276.7% Upside Market Cap483.9 M P/E-3.1x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Lexeo Therapeutics Inc (LXEO)
Fair Value-2.7% Downside Fair Analyst351.2% Upside Market Cap377.7 M P/E-4.2x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
MapLight Therapeutics Inc (MPLT)
Fair Value28.7% Upside Undervalued Analyst161.6% Upside Market Cap551.9 M P/E-2.8x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
MDxHealth SA ADR (MDXH)
Fair Value14.7% Upside Fair Analyst485.8% Upside Market Cap23.679 M P/E-0.7x Yield0.0% HealthFair
  NASDAQ
Medicus Pharma Ltd (MDCX)
Fair Value-16.0% Downside Fair Market Cap16.975 M P/E-0.4x Yield0.0% HealthWeak
  NASDAQ
Metagenomi Inc (MGX)
Fair Value32.1% Upside Undervalued Analyst518.3% Upside Market Cap46.306 M P/E-0.5x Yield0.0% HealthWeak
  NASDAQ
Mineralys Therapeutics Inc (MLYS)
Fair Value-20.9% Downside Overvalued Analyst79.0% Upside Market Cap2.411 B P/E-15.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Mink Therapeutics Inc (INKT)
Fair Value-25.0% Downside Overvalued Analyst257.1% Upside Market Cap54.552 M P/E-4.4x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Neuphoria Therapeutics Inc (NEUP)
Fair Value27.3% Upside Undervalued Analyst80.9% Upside Market Cap20.645 M P/E-1.2x Yield0.0% HealthFair
  NASDAQ
Neurosense Therapeutics Ltd (NRSN)
Fair Value-1.0% Downside Fair Market Cap17.671 M P/E-1.7x Yield0.0% HealthWeak
  NASDAQ
Nuvectis Pharma Inc (NVCT)
Fair Value-35.2% Downside Overvalued Analyst83.1% Upside Market Cap617.4 M P/E-20.3x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
OKYO Pharma (OKYO)
Fair Value-17.9% Downside Fair Analyst430.8% Upside Market Cap78.194 M P/E-9.2x Yield0.0% HealthFair
  NASDAQ
Onconetix Inc (ONCO)
Fair Value48.0% Upside Undervalued Market Cap3.291 M P/E-0.3x Yield0.0% HealthFair
  NASDAQ
OSR Holdings Inc (OSRH)
Fair Value21.6% Upside Undervalued Market Cap15.552 M P/E-1.6x Yield0.0% HealthFair
  NASDAQ
Palatin Technologies Inc (PTN)
Fair Value-23.8% Downside Overvalued Analyst585.9% Upside Market Cap14.021 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ
PepGen Ltd (PEPG)
Fair Value6.5% Upside Fair Analyst252.5% Upside Market Cap197.1 M P/E-2.7x Yield0.0% HealthFair
  NASDAQ
Polyrizon Ltd (PLRZ)
Fair Value-47.1% Downside Overvalued Market Cap21.695 M P/E-6.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Prime Medicine Inc (PRME)
Fair Value-17.1% Downside Fair Analyst113.0% Upside Market Cap547.9 M P/E-3.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
ProKidney Corp (PROK)
Fair Value-13.0% Downside Fair Analyst275.4% Upside Market Cap495.4 M P/E-4.7x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
ProMIS Neurosciences Inc (PMN)
Fair Value13.0% Upside Fair Analyst168.6% Upside Market Cap131.9 M P/E-3.3x Yield0.0% HealthWeak
  NASDAQ Featured in High-Momentum Stocks
Explore listed stocks on NASDAQ with company information and fair value data.